Daily Stock Opinions and Ratings

Opinions

Don Reed Atrium Innovations. ATB-T DON'T BUY Mar 15, 2011

If he bought it a month ago he would expect to sell it 5 years from now. Not really cheap. Would not buy it today and sell in 30 days. Would look at averaging the price.

Don Reed

Unknown

Unlock Rating

$15.330

Stock price when the opinion was issued

Consumer Products

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

PAST TOP PICK

(Top Pick Nov 16/09, Down 2%) Nutrition business. Biggest maker of high quality supplements sold through practitioners. A German product changed classification from drug to food additive. They grow through acquisition and he expects them to do that next year.

SELL

In the nutri-ceuticals environment with drugs, health foods, etc. Hard to read how the market place is playing out in this sector. Prefers Paladin Labs (PLB-T) and would into this one instead.

PAST TOP PICK

(A Top Pick Dec 23/09. Down 0.46%.) Canadian Based multinational consumer products company in the high quality vitamin supplements sold mostly though practitioners. Had to change a German product from a health supplement into a food additive, which has held back the sales. New product is selling well. Very low multiple. Good risk/reward. Still a Buy.

PAST TOP PICK

(A Top Pick Aug 11/10. Down 7.38%.) Largest US manufacturer and one of the largest in Europe of high quality vitamins and other supplements. Also made acquisitions that have got them into the health store business. This is a buying opportunity.

SELL

Vitamin Business. Likes long term demographics of vitamin and supplement business. Unfortunately a lot of business is in Europe and is hurting them. Thinks there is definitely better places to be. He sold his holdings.

TOP PICK

5.75% bond maturing August 31/18. This is a convertible debenture. Company has fantastic interest coverage and very low debt.

HOLD

(Market Call Minute.) The negative on this is that they are big in Europe and the positive is that there is lots of consolidation in the industry.

PAST TOP PICK

(A Top Pick Nov 28/12. Up 9.9%.) 5.75% bond maturing August 31/18.

SELL

(Market Call Minute) Tender your shares. Gov’t may be reluctant to see this one go.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Don Reed Atrium Innovations. ATB-T DON'T BUY Mar 15, 2011

You might be interested:

Atrium Innovations.(ATB-T)

Atrium Innovations.(ATB-T)

Atrium Innovations.(ATB-T)

Atrium Innovations.(ATB-T)

Atrium Innovations.(ATB-T)

Atrium Innovations.(ATB-T)

Atrium Innovations.(ATB-T)

Atrium Innovations.(ATB-T)

Atrium Innovations.(ATB-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Chris Blumas

Stockchase Insights

Jim Cramer - Mad Money

Eric Nuttall

The Panic-Proof Portfolio (Stockchase Research)